This inventor holds 2 USPTO granted patents. Top assignees: Natural Environment Research Council, Oravax-Merieux Co., Oravax, Inc.. Active years: 1997-1998.
Location History:
- Cambridge, MA (US) (1997)
- Newton, MA (US) (1998)
Company Filing History:
1 out of 9 
1 out of 4 
1 out of 10 Years Active: 1997-1998
Title: Jacques Pappo: Innovator in Vaccine Development
Introduction
Jacques Pappo is a notable inventor based in Cambridge, MA (US), recognized for his contributions to vaccine development. He holds 2 patents that focus on innovative methods for combating bacterial infections, particularly those caused by Helicobacter pylori.
Latest Patents
Pappo's latest patents include a multimeric, recombinant urease vaccine. This invention provides methods and compositions for prophylactic and antibacterial therapy for Helicobacter infections in humans. The immunogenic composition consists of multimeric complexes made up of recombinant, enzymatically inactive Helicobacter pylori urease. Each complex is formed from six Urease A subunits and six Urease B subunits. Additionally, he has developed a method for oral immunization using a particulate antigen delivery system. This method aims to induce a mucosal and systemic immune response by administering an effective amount of a Bluetongue antigen in the form of virus-like particles.
Career Highlights
Throughout his career, Jacques Pappo has worked with several companies, including Oravax, Inc. and Oravax-Merieux Company. His work has significantly advanced the field of immunology and vaccine development.
Collaborations
Pappo has collaborated with notable professionals in the field, including Thomas P Monath and Farshad Guirakhoo. These collaborations have contributed to the success of his innovative projects.
Conclusion
Jacques Pappo's work in vaccine development showcases his commitment to advancing medical science. His patents reflect a deep understanding of immunology and a dedication to improving public health.